脑梗死的溶栓治疗——离我们到底有多远?  

Cerebral Infarction Thrombolytic Therapy How Far Away?

作　　者：孙晓培[1] 李明[1] 刘宣[1] 郭岩[1] 刘彩丽[1] 杨滨泽[1] 王为[1] 

机构地区：[1]大连医科大学附属第一医院神经内科,辽宁大连116011

出　　处：《医学与哲学（B）》2013年第10期75-77,共3页Medicine & Philosophy(B)

摘　　要：急性脑梗死是我国的常见病、多发病,目前最有效的药物治疗手段是进行溶栓治疗。但我国的溶栓率还比较低,与发达国家相比仍有很大差距。主要原因为老百姓知晓率低、院前延误、城市急救系统运力不足、卒中中心的建设不够及医源性因素等几个方面,以后应该加强溶栓宣传、加强城市急救中心建设、加强卒中中心建设及对各级医院的神经科医生进行相关培训,提高接受溶栓患者的比例,从而让更多的患者受益。Acute cerebral infarction is commonly seen in China, and nowadays the most effective mean of medications is thrombolytic therapy. However, the thrombolysis successful rate is comparatively lower than the developed countries, which means that there is still a big gap when compared with the developed countries. And the reasons can be summarized as the low awareness of civilians, the pre-hospital delay, the shortage of city emergency system capacity, the insufficient of stroke centers and some other iatrogenic causes. The follow- up measures consist of strengthening the publicity of thrombolysis, increasing construction of city emergency centers and stroke centers, and conducting related training to all levels of the hospital＇s neurologists, all are increasing the proportion of patients receiving thrombolysis, improving benefits for more patients.

关 键 词：脑梗死 溶栓治疗 院前延误 

分 类 号：R743.33[医药卫生—神经病学与精神病学]